Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

753 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Factors Associated With and Outcomes After Ventricular Fibrillation Before and During Primary Angioplasty in Patients With ST-Segment Elevation Myocardial Infarction.
Jabbari R, Risgaard B, Fosbøl EL, Scheike T, Philbert BT, Winkel BG, Albert CM, Glinge C, Ahtarovski KA, Haunsø S, Køber L, Jørgensen E, Pedersen F, Tfelt-Hansen J, Engstrøm T. Jabbari R, et al. Among authors: jorgensen e. Am J Cardiol. 2015 Sep 1;116(5):678-85. doi: 10.1016/j.amjcard.2015.05.037. Epub 2015 Jun 3. Am J Cardiol. 2015. PMID: 26150175
Predictors of coronary in-stent restenosis: importance of angiotensin-converting enzyme gene polymorphism and treatment with angiotensin-converting enzyme inhibitors.
Jørgensen E, Kelbaek H, Helqvist S, Jensen GV, Saunamäki K, Kastrup J, Havndrup O, Bundgaard H, Kyst Madsen J, Christiansen M, Andersen PS, Reiber JH. Jørgensen E, et al. J Am Coll Cardiol. 2001 Nov 1;38(5):1434-9. doi: 10.1016/s0735-1097(01)01580-7. J Am Coll Cardiol. 2001. PMID: 11691520 Free article.
Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial.
Kastrup J, Jørgensen E, Rück A, Tägil K, Glogar D, Ruzyllo W, Bøtker HE, Dudek D, Drvota V, Hesse B, Thuesen L, Blomberg P, Gyöngyösi M, Sylvén C; Euroinject One Group. Kastrup J, et al. Among authors: jorgensen e. J Am Coll Cardiol. 2005 Apr 5;45(7):982-8. doi: 10.1016/j.jacc.2004.12.068. J Am Coll Cardiol. 2005. PMID: 15808751 Free article. Clinical Trial.
Changes in circulating mesenchymal stem cells, stem cell homing factor, and vascular growth factors in patients with acute ST elevation myocardial infarction treated with primary percutaneous coronary intervention.
Wang Y, Johnsen HE, Mortensen S, Bindslev L, Ripa RS, Haack-Sørensen M, Jørgensen E, Fang W, Kastrup J. Wang Y, et al. Among authors: jorgensen e. Heart. 2006 Jun;92(6):768-74. doi: 10.1136/hrt.2005.069799. Epub 2005 Oct 26. Heart. 2006. PMID: 16251230 Free PMC article.
The Stenting Coronary Arteries in Non-stress/benestent Disease (SCANDSTENT) trial.
Kelbaek H, Thuesen L, Helqvist S, Kløvgaard L, Jørgensen E, Aljabbari S, Saunamäki K, Krusell LR, Jensen GV, Bøtker HE, Lassen JF, Andersen HR, Thayssen P, Galløe A, van Weert A; SCANDSTENT Investigators. Kelbaek H, et al. Among authors: jorgensen e. J Am Coll Cardiol. 2006 Jan 17;47(2):449-55. doi: 10.1016/j.jacc.2005.10.045. Epub 2005 Dec 9. J Am Coll Cardiol. 2006. PMID: 16412876 Free article. Clinical Trial.
753 results